BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6119925)

  • 1. Nadolol eye drops in glaucoma and ocular hypertension: a controlled clinical study of dose response and duration of action.
    Krieglstein GK
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 217(4):309-14. PubMed ID: 6119925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nadolol and labetalol: comparative efficacy of two beta-blocking agents in glaucoma.
    Krieglstein GK; Kontić D
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 216(4):313-7. PubMed ID: 6114677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative multiple-dose intraocular pressure responses of nadolol and timolol in glaucoma and ocular hypertension.
    Krieglstein GK; Mohamed J
    Acta Ophthalmol (Copenh); 1982 Apr; 60(2):284-92. PubMed ID: 6127861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diacetyl nadolol: 3-month ocular hypotensive effect in glaucomatous eyes.
    Duzman E; Rosen N; Lazar M
    Br J Ophthalmol; 1983 Oct; 67(10):668-73. PubMed ID: 6137236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of orally administered nadolol on the intraocular pressure in normal volunteers.
    Williamson J; Atta HR; Kennedy PA; Muir JG
    Br J Ophthalmol; 1985 Jan; 69(1):38-40. PubMed ID: 2856892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
    Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of beta-blocking agent carteolol on healthy volunteers and glaucoma patients (author's transl)].
    Negishi C; Ueda S; Kanai A; Nakajima A; Funahashi M; Kitazawa Y; Komemushi S
    Nippon Ganka Gakkai Zasshi; 1981 Jan; 85(1):57-66. PubMed ID: 6114632
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative efficacy of orally and topically administered beta blockers for chronic simple glaucoma.
    Williamson J; Young JD; Atta H; Muir G; Kadom H
    Br J Ophthalmol; 1985 Jan; 69(1):41-5. PubMed ID: 2856893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of betaxolol and timolol in open angle glaucoma and ocular hypertension.
    Feghali JG; Kaufman PL; Radius RL; Mandell AI
    Acta Ophthalmol (Copenh); 1988 Apr; 66(2):180-6. PubMed ID: 2898859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular hypotensive effect of atenolol (Tenormin, I.C.I.). A new beta-adrenergic blocker.
    Elliot MJ; Cullen PM; Phillips CI
    Br J Ophthalmol; 1975 Jun; 59(6):296-300. PubMed ID: 240378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atenolol versus propranolol. A comparison of ocular hypotensive effect of an oral dose.
    Macdonald MJ; Cullen PM; Phillips CI
    Br J Ophthalmol; 1976 Nov; 60(11):789-91. PubMed ID: 12782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of metoprolol on IOP (author's transl)].
    Krieglstein GK
    Klin Monbl Augenheilkd; 1978 Nov; 173(5):632-7. PubMed ID: 366263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term ocular and systemic effects of topically applied metoprolol tartrate in glaucoma and ocular hypertension.
    Krieglstein GK
    Acta Ophthalmol (Copenh); 1981 Feb; 59(1):15-20. PubMed ID: 7010891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metoprolol eye drops in the treatment of glaucoma. A double-blind single-dose trial of a beta1-adrenergic blocking drug.
    Ros FE; Dake CL; Nagelkerke NJ; Greve EL
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1978 Jun; 206(4):247-54. PubMed ID: 356658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diacetyl derivative of nadolol. I. Ocular pharmacology and short-term ocular hypotensive effect in glaucomatous eyes.
    Duzman E; Chen CC; Anderson J; Blumenthal M; Twizer H
    Arch Ophthalmol; 1982 Dec; 100(12):1916-9. PubMed ID: 6756362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effectiveness and mechanism of action of thymoptic in glaucoma].
    Shmyreva VF; Fridman NV; Makashova NV
    Vestn Oftalmol; 1982; (3):8-10. PubMed ID: 6126027
    [No Abstract]   [Full Text] [Related]  

  • 17. [The influence of metoprolol eye drops on intraocular pressure (author's transl)].
    Bucheli J; Aeschlimann J; Gloor B
    Klin Monbl Augenheilkd; 1980; 177(2):146-50. PubMed ID: 7005514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-response study of oral atenolol administered once daily in patients with raised intra-ocular pressure.
    Stenkula E; Wettrell K
    Graefes Arch Clin Exp Ophthalmol; 1982; 218(2):96-8. PubMed ID: 7042481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.
    El Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    J Int Med Res; 1980; 8(3):193-8. PubMed ID: 6104614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stereospecificity of beta-blocker effects on the glaucomatous eye].
    Krieglstein GK; Schrems W
    Fortschr Ophthalmol; 1984; 81(2):127-9. PubMed ID: 6145665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.